497 related articles for article (PubMed ID: 15556972)
1. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2.
Kilic U; Kilic E; Soliz J; Bassetti CI; Gassmann M; Hermann DM
FASEB J; 2005 Feb; 19(2):249-51. PubMed ID: 15556972
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways.
Kilic E; Kilic U; Soliz J; Bassetti CL; Gassmann M; Hermann DM
FASEB J; 2005 Dec; 19(14):2026-8. PubMed ID: 16207820
[TBL] [Abstract][Full Text] [Related]
3. Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells.
Weishaupt JH; Rohde G; Pölking E; Siren AL; Ehrenreich H; Bähr M
Invest Ophthalmol Vis Sci; 2004 May; 45(5):1514-22. PubMed ID: 15111610
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 2 applied to the optic nerve after axotomy increases Bcl-2 and decreases Bax in ganglion cells by activating the extracellular signal-regulated kinase signaling pathway.
Ríos-Muñoz W; Soto I; Duprey-Díaz MV; Blagburn J; Blanco RE
J Neurochem; 2005 Jun; 93(6):1422-33. PubMed ID: 15935058
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 In vivo.
Kermer P; Klöcker N; Labes M; Bähr M
J Neurosci; 2000 Jan; 20(2):2-8. PubMed ID: 10632601
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats.
Sola A; Rogido M; Lee BH; Genetta T; Wen TC
Pediatr Res; 2005 Apr; 57(4):481-7. PubMed ID: 15718373
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor prevents axotomized retinal ganglion cell death through MAPK and PI3K signaling pathways.
Nakazawa T; Tamai M; Mori N
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3319-26. PubMed ID: 12356841
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation.
Kretz A; Happold CJ; Marticke JK; Isenmann S
Mol Cell Neurosci; 2005 Aug; 29(4):569-79. PubMed ID: 15936213
[TBL] [Abstract][Full Text] [Related]
9. Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways.
Kilic U; Kilic E; Järve A; Guo Z; Spudich A; Bieber K; Barzena U; Bassetti CL; Marti HH; Hermann DM
J Neurosci; 2006 Nov; 26(48):12439-46. PubMed ID: 17135405
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8.
Chong ZZ; Lin SH; Kang JQ; Maiese K
J Neurosci Res; 2003 Mar; 71(5):659-69. PubMed ID: 12584724
[TBL] [Abstract][Full Text] [Related]
11. Effects of supplemental erythropoietin on its receptor expression and signal transduction pathways in rat model of retinal detachment.
Xie Z; Chen F; Wu X; Zhuang C; Zhu J; Wang J; Ji H; Wang Y; Hua X
Curr Eye Res; 2012 Feb; 37(2):138-44. PubMed ID: 22251399
[TBL] [Abstract][Full Text] [Related]
12. Effects of epigallocatechin-3-gallate on rat retinal ganglion cells after optic nerve axotomy.
Peng PH; Chiou LF; Chao HM; Lin S; Chen CF; Liu JH; Ko ML
Exp Eye Res; 2010 Apr; 90(4):528-34. PubMed ID: 20114044
[TBL] [Abstract][Full Text] [Related]
13. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
14. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
Erickson-Miller CL; Pelus LM; Lord KA
Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity.
Dzietko M; Felderhoff-Mueser U; Sifringer M; Krutz B; Bittigau P; Thor F; Heumann R; Bührer C; Ikonomidou C; Hansen HH
Neurobiol Dis; 2004 Mar; 15(2):177-87. PubMed ID: 15006687
[TBL] [Abstract][Full Text] [Related]
16. ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD.
Shen J; Wu Y; Xu JY; Zhang J; Sinclair SH; Yanoff M; Xu G; Li W; Xu GT
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):35-46. PubMed ID: 19628748
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis.
Sättler MB; Merkler D; Maier K; Stadelmann C; Ehrenreich H; Bähr M; Diem R
Cell Death Differ; 2004 Dec; 11 Suppl 2():S181-92. PubMed ID: 15459752
[TBL] [Abstract][Full Text] [Related]
18. Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells.
Ammarguellat F; Llovera M; Kelly PA; Goffin V
Biochem Biophys Res Commun; 2001 Jun; 284(4):1031-8. PubMed ID: 11409898
[TBL] [Abstract][Full Text] [Related]
19. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
[TBL] [Abstract][Full Text] [Related]
20. TLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration.
Kilic U; Kilic E; Matter CM; Bassetti CL; Hermann DM
Neurobiol Dis; 2008 Jul; 31(1):33-40. PubMed ID: 18486483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
